A recent review published in the journal Cancers highlighted the promising antitumor effect of CBD.
Specifically, the review confirmed what has been published in recent years, namely a significant antitumor effect exerted by CBD on numerous types of tumors reproduced in vitro or in animal models (glioma, adenocarcinoma of the lung, breast, prostate, and colorectal, to name just a few).
The study shows that the mechanisms of action through which CBD fulfills its antitumor function (not only antiproliferative and proapoptotic, but also antimetastatic) are multiple and differ depending on the target cells.
Without a doubt, CBD's ability to modulate the inflammation and oxidative stress cascade involved in the genesis of many neoplastic processes through various (partly still unknown) mechanisms appears to play a fundamental role.
Another interesting fact is the safety of CBD, with a near absence of significant side effects and the inability to alter key vital parameters such as blood pressure, heart rate, and neurological functions.
In conclusion, this review highlights the great potential of CBD as an anticancer drug, emphasizing the need to initiate clinical trials that can confirm these results and allow cancer patients to benefit from them.
by 
